Cancer Genetics and Epigenetics 2024, Vol.12, No.5, 279-293 http://medscipublisher.com/index.php/cge 289 Boujemaa M., Mighri N., Chouchane L., Boubaker M.S., Abdelhak S., Boussen H., and Hamdi Y., 2022, Health influenced by genetics: A first comprehensive analysis of breast cancer high and moderate penetrance susceptibility genes in the tunisian population, PLoS One, 17(3): e0265638. https://doi.org/10.1371/journal.pone.0265638 PMID: 35333900 PMCID: PMC8956157 Cai X.P., 2024, Applications of gene editing and gene therapy in the treatment of genetic disorders, International Journal of Molecular Medical Science, 14(1): 1-7. https://doi.org/10.5376/ijmms.2024.14.0001 Čelešnik H., and Potočnik U., 2023, Blood-Based mRNA tests as emerging diagnostic tools for personalised medicine in breast cancer, Cancers, 15(4): 1087. https://doi.org/10.3390/cancers15041087 PMID: 36831426 PMCID: PMC9954278 Cescon D.W., Bratman S.V., Chan S.M., and Siu L.L., 2020, Circulating tumor DNA and liquid biopsy in oncology, Nature Cancer, 1(3): 276-290. https://doi.org/10.1038/s43018-020-0043-5 PMID: 35122035 Chen M., and Zhao H.Y., 2019, Next-generation sequencing in liquid biopsy: cancer screening and early detection, Human Genomics, 13(1): 34. https://doi.org/10.1186/s40246-019-0220-8 PMID: 31370908 PMCID: PMC6669976 Cobain E.F., Milliron K.J., and Merajver S.D., 2016, Updates on breast cancer genetics: clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer, Seminars in Oncology, 43(5): 528-535. https://doi.org/10.1053/j.seminoncol.2016.10.001 PMID: 27899183 Costain G., Jobling R., Walker S., Reuter M.S., Snell M., Bowdin S., Cohn R.D., Dupuis L., Hewson S., Mercimek-Andrews S., Shuman C., Sondheimer N., Weksberg R., Yoon G., Meyn M.S., Stavropoulos D.J., Scherer S.W., Mendoza-Londono R., and Marshall C.R., 2018, Periodic reanalysis of whole-genome sequencing data enhances the diagnostic advantage over standard clinical genetic testing, European Journal of Human Genetics, 26(5): 740-744. https://doi.org/10.1038/s41431-018-0114-6 PMID: 29453418 PMCID: PMC5945683 Couch F.J., Hart S.N., Sharma P., Toland A.E., Wang X., Miron P., Olson J.E., Godwin A.K., Pankratz V.S., Olswold C., Slettedahl S., Hallberg E., Guidugli L., Davila J.I., Beckmann M.W., Janni W., Rack B., Ekici A.B., Slamon D.J., Konstantopoulou I., Fostira F., Vratimos A., Fountzilas G., Pelttari L.M., Tapper W.J., Durcan L., Cross S.S., Pilarski R., Shapiro C.L., Klemp .J, Yao S., Garber J., Cox A., Brauch H., Ambrosone C., Nevanlinna H., Yannoukakos D., Slager S.L., Vachon C.M., Eccles D.M., and Fasching P.A., 2015, Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer,. Journal of Clinical Oncology, 33(4): 304-311. https://doi.org/10.1200/JCO.2014.57.1414 PMID: 25452441 PMCID: PMC4302212 Crosby D., Bhatia S., Brindle K.M., Coussens L.M., Dive C., Emberton M., Esener S., Fitzgerald R.C., Gambhir S.S., Kuhn P., Rebbeck T.R., and Balasubramanian S., 2022, Early detection of cancer, Science, 375(6586): eaay9040. https://doi.org/10.1126/science.aay9040 Dalivandan S.T., Plummer, J., and Gayther, S., 2021, Risks and function of breast cancer susceptibility alleles, Cancers, 13(16): 3953. https://doi.org/10.3390/cancers13163953 PMID: 34439109 PMCID: PMC8393346 Dorling L., Carvalho S., Allen J., González-Neira A., Luccarini C., Wahlström C., Pooley K.A., Parsons M., Fortuno C., Wang Q., Bolla M.K., Dennis J., Keeman R., Alonso M.R., Alvarez N., Herráez B., Fernández V., Núñez-Torres R., Osorio A., Valcich J., Li M., Törngren T., Harrington P., Baynes C., Conroy D.M., Decker B., Fachal L., Mavaddat N., Ahearn T., Aittomaki K., Antonenkova N., Arnold N., Arveux P., Ausems M., Auvinen P., Becher H., Beckmann M., Behrens S., Bermisheva M., Białkowska K., Blomqvist C., Bogdanova N., Bogdanova-Markov N., Bojesen S., Bonanni B., Børresen-Dale A., Brauch H., Bremer M., Briceño I., Brüning T., Burwinkel B., Cameron D., Camp N., Campbell A., Carracedo Á., Castelao J., Cessna M., Chanock S., Christiansen H., Collée J., Cordina-Duverger E., Cornelissen S., Czene K., Dörk T., Ekici A.B., Engel C., Eriksson M., Fasching P., Figueroa J., Flyger H., Försti A., Gabrielson M., Gago-Domínguez M., Georgoulias V., Gil F., Giles G., Glendon G., García E., Alnæs G., Guénel P., Hadjisavvas A., Haeberle L., Hahnen E., Hall P., Hamann U., Harkness E., Hartikainen J., Hartman M., He W., Heemskerk-Gerritsen B., Hillemanns P., Hogervorst F., Hollestelle A., Ho W., Hooning M., Howell A., Humphreys K., Idris F., Jakubowska A., Jung A., Kapoor P., Kerin M., Khusnutdinova E., Kim S., Ko Y., Kosma V., Kristensen V., Kyriacou K., Lakeman I., Lee J., Lee M., Li J., Lindblom A., Lo W., Loizidou M., Lophatananon A., Lubiński J., MacInnis R., Madsen M., Mannermaa A., Manoochehri M., Manoukian S., Margolin S., Martínez M., Maurer T., Mavroudis D., Mclean C., Meindl A., Mensenkamp A., Michailidou K., Miller N., Taib N., Muir K., Mulligan A., Nevanlinna H., Newman W., Nordestgaard B., Ng P., Oosterwijk J., Park S., Park-Simon T., Peŕez J., Peterlongo P., Porteous D., Prajzendanc K., Prokofyeva D., Radice P., Rashid M., Rhenius V., Rookus M., Rüdiger T., Saloustros E., Sawyer E., Schmutzler R., Schneeweiss A., Schürmann P., Shah M., Sohn C., Southey M., Surowy H., Suvanto M., Thanasitthichai S., Tomlinson I., Torres D., Truong T., Tzardi M., Valova Y., Asperen C., Dam R., Ouweland A., Kolk L., Veen E., Wendt C., Williams J., Yang X., Yoon S., Zamora M., Evans D., Hoya M., Simard J., Antoniou A., Borg Å., Andrulis I., Chang-Claude J., García-Closas M., Chenevix-Trench G., Milne R., Pharoah P., Schmidt M., Spurdle A., Vreeswijk M., Benítez J., Dunning A., Kvist A., Teo S.H., Devilee P., and Easton D.F., 2021, Breast cancer risk genes-association analysis in more than 113 000 women, The New England Journal of Medicine, 384(5): 428-439. https://doi.org/10.1056/NEJMoa1913948
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==